中医药通报

TraditionalChineseMedicineJournal633,,:3(200032)150,199952198/10,19721818/10180130%[1],,,,11914,Ewing[2]PrecancerousDiseasesandprecancerouslesions,Especiallyinbreast::,,,;,,,,[3],,,[4]WHO20%,[5][6],[7]200685464TraditionalChineseMedicineJournal2211,,,,,,,212Page[8],,,(),,,,,;[9],213,21311XCTMRIECT21312,,,[10]21313(FNACD)DNA(FCM)DNAPCR21421411C2erbB22[11]C2erbB22,,21412PRLR,(PRLR),Gill[12]PRLR21413Ras[13]RasP2121414Bcl22[14],,Bcl22P53c2myc(telomerase)PCNABRCA13,,All2red[15]:;MCF10AT311DMBAMNUDMBA[16][17]WistarDMBA5mg/(2ml),[18][19]SD7mg/100mg[20][21]SD100mg/kg,DMBA9215%312MCF10ATMCF10ATMCF102AneoT,MCF10AH2RasT24MCF10A36[22]MCF10ATKarma2nos(KCI)[23]MCF10AT(1107),:,[24]MCF10AT[25]Visscher[26]MCF10ATTraditionalChineseMedicineJournal654411,(ER)[27],(TAM),,,,;,P450,[28],,,,HER22VEGF41241211,,;,[29],65%,,,,,,,,,,,[30],,,,41212[31]X,X,(,)XE2PX9118%X,E2,P,E2,,,--,,,,,[32],MCF210AT,MCF210AT,,MCF210AT5,:(1),,,(2)200685466TraditionalChineseMedicineJournal(3),(4)C2erbB22Bcl22RasPRLR(5)MCF10AT,(6),,,[1],,,.[J].,2001,6(4):219-221.[2]EwingJ.PrecancerousDiseasesandpre2cancerouslesions,Especiallyinbreast.MedRe2cord[M].1994,86:951-958.[3]LakhaniSR.Thetransitionfromhyperplasi2atoinvasioncancinomaofthebreast[J].JPathol,1999,187(3):272-278.[4]..[J],2000,(5):310.[5].[M].:,1986:75.[6].[J].,2000,20(5):261.[7]..:,.[M].:,1997:1599.[8]PageDL,DupontWD,RogersLW,Ra2dosMS.Atypicalhyperplasticlesionsofthefe2malebreast.Along-termfollow-upstudy[J].Cancer.1985,55(11):2698-708.[9]..:.[M].:,1999.23.[10]OkazakiA,OkazakiM,HirtaK,etal.Progressofductoscopyofthebreast[J].NipponCekagakkaiZasski,1996,97(5):357.[11],,.c-erbB-2p53[J].,1997,119(5):342-345.[12]SGill,DPeston,BKVonderhaar,etal.Expressionofprolactinreceptorsinnormal,benign,andmalignantbreasttissue:animmuno2histologicalstudy[J].JClinPathol.2001,54:956-966.[13],,.rasP21[J].,1994,23(5):302-303.[14],,,.p53bcl-2[J].,2000,27(5):329-332.[15]AllredDC,MedinaD.Introduction:mod2elsofpremalignantbreastdisease[J].JMam2maryGlandBiolNeoplasia.2000,5(4):339-340.[16]HenryJ.Thompson,MeenakshiSingh.Ratmodelsofpremalignantbreastdisease[J].JMammaryGlandBiolNeoplasia.2000,5(4):409-420.[17],.[J].,2001,16(2):110-112.[18],,.[J].,2002,8(4):454-456.[19],,,.DMBA[J].,2002,29(8):579-582.[20],,,.[J].,2001,18(4):372-373.[21],,,.[J].,2003,22(10):622-625.[22]MillerFR.Xenograftmodelsofpremalig2nantbreastdisease[J].JMammaryGlandBiolNeoplasia.2000,5(4):379-391.[23].DawsonPJ,WolmanSR,TaitL,etal.Amodelsfortheevolutionofcancerfromprolifer2ativebreastdisease[J].AMJPath.1996,148:313-3191.[24]PengX,WoodS,BratescuL,etal.RetinoidssuppresspremalignantMCF10ATbutnotmalignantMCF10CA1abreastepithelialcellsinvivo.Roleofretinoicacidreceptorbeta2ex2pression[J].CancerLett.2005,222(2):153-163.[25]HeppnerGH,WolmanSR.MCF-10AT:AModelforHumanBreastCancerDevelopment[J].BreastJ.1999,5(2):122-129.[26]VisscherDW,NanjiaMP,HepponerG,etal.TamixifensuppresseshistologicprogressiontoatypiaandDCISinMCFOATxenografts,amodelofearlyhumanbreastcancer[J].BreastCancerResTreat,2001,65(1):41-47.[27]TelangNT,BradlowHL,OsborneMP.Effectoftamoxifenonmammarypreneoplasia:rele2vancetochemopreventiveintervention[J].CancerDetectPrev.1994,18(4):313-321.[28]SourlaA,LuoS,LabrieC,etal.Mor2phologicalchangesinducedby6-monthtreat2mentofintactandovariectomizedmicewithtamoxifenandthepureantiestrogenEM-800[J].Endocrinology.1997,138(12):5605-5617.[29].[J].,2003,25(3):3-5.[30],,,.[J].,2005,12(8):3-4.[31],.16[J].,2002,9(2):176-178.[32].MCF210AT[D].:,2006.